Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
Status:
Terminated
Trial end date:
2020-09-24
Target enrollment:
Participant gender:
Summary
This phase II trial investigates whether patients greater than or equal to 65 years of age
diagnosed with myeloma or another plasma cell malignancy will have better outcomes with
transplant followed by maintenance therapy, as primarily measured by progression-free
survival, versus non-transplant approaches.